Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-21
2005-06-21
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S211110, C514S303000, C514S409000, C514S412000, C540S543000, C540S578000, C546S018000, C546S118000, C548S411000, C548S453000
Reexamination Certificate
active
06908926
ABSTRACT:
Disclosed is a novel class of substituted imidazole compounds, pharmaceutical compositions containing them and uses of these compounds in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, these compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial. These imidazoles compounds have the formula Iwherein R1, R2, R3, R4, R5, R6, A, X, Y and Z are as defined in the specification.
REFERENCES:
patent: 4767778 (1988-08-01), Arrang et al.
patent: 5091390 (1992-02-01), Ardecky et al.
patent: 5262537 (1993-11-01), Huang et al.
patent: 5578616 (1996-11-01), Aslanian et al.
patent: 27 00 012 (1977-07-01), None
patent: 33 02 125 (1984-07-01), None
patent: 33 02 126 (1984-07-01), None
patent: 0 197 840 (1986-10-01), None
patent: 0 214 058 (1987-03-01), None
patent: 0 338 939 (1989-10-01), None
patent: 0 458 661 (1991-11-01), None
patent: 0 494 010 (1992-07-01), None
patent: 0 499 521 (1992-08-01), None
patent: 0 531 219 (1993-03-01), None
patent: 0 531 874 (1993-03-01), None
patent: 0 589 665 (1994-03-01), None
patent: 2 337 726 (1980-03-01), None
patent: 1 524 481 (1978-09-01), None
patent: 2 158 440 (1985-11-01), None
patent: 6-312926 (1994-08-01), None
patent: WO 91/17146 (1991-11-01), None
patent: WO 92/15567 (1992-09-01), None
patent: WO 92/18115 (1992-10-01), None
patent: WO 93/12093 (1993-06-01), None
patent: WO 93/12107 (1993-06-01), None
patent: WO 93/12108 (1993-06-01), None
patent: WO 93/14070 (1993-07-01), None
patent: WO 93/20061 (1993-10-01), None
patent: WO 94/17058 (1994-08-01), None
patent: WO 95/06037 (1995-03-01), None
patent: WO 95/11894 (1995-05-01), None
patent: WO 95/14007 (1995-05-01), None
patent: WO 96/38141 (1996-12-01), None
patent: WO 96/38142 (1996-12-01), None
patent: WO 96/40126 (1996-12-01), None
patent: WO 98/29119 (1998-07-01), None
CAS printout for Stocker et al. Chem. Abs. 112:216653, 1990.
CAS printout for Arcari et al. Chem 80:45756.
CAS printout for Enari et al.
CAS printout for Klutchko et al.
CAS printout for Vincent et al.
CAS printout for Suzukiet et al.
CAS printout for Thorwart et al.
CAS printout for Remelli et al.
CAS printout for Hauck et al.
CAS printout for Yutilov et al.
CAS printout for Stocker et al.
Williams et al., Journal of Pharmaceutical Sci., vol. 71, No. 1, pp. 119-120 (Jan. 1982).
Piper et al., Can. J. Chem., vol. 61, pp. 2721-2728 (1983).
Casella et al., J. Am. Chem. Soc., vol. 103, pp. 6338-6347 (1981).
Nagarajan et al., Indian Journal of Chem., vol. 15B, pp. 629-634 (Jul. 1977).
Emmett et al, J. Med. Chem., vol. 25, pp. 1168-1174 (1982).
Vitali et al., Chim. Ital., vol. 94, pp. 296-305 (1964).
Arcari et al., Arzneim. Forschung, vol. 34, pp. 1467-1471 (1984).
Habermehl et al., Heterocycles, vol. 5, pp. 127-134 (1976).
Hepp et al., Arch. Pharm. (Weinheim), vol. 313, pp. 756-762 (1980).
Arcari, et al., Chemical Abstract, 87:201535, pp. 730-731 (1977).
Klutchko et al., J. Heterocyclic Chem., vol. 28, pp. 97-108 (1991).
Lovenberg et al., Molecular Pharm., vol. 55, pp. 1101-1107 (1999).
Leurs et al., Progress in Drug Research, vol. 45, pp. 107-165 (1995).
Stark et al, Drugs of The Future, vol. 21, No. 5, pp. 507-520 (1996).
Vitali et al., Farmaco Ed. Sci., vol. 22, pp. 821-845 (1967).
Krause et al., J. Med. Chem., vol. 38, pp. 4070-4079 (1995).
Andersen Knud Erik
Dörwald Florencio Zaragoza
Hurnaus Rudolf
Jørgensen Tine Krogh
Krist Bernd
Bork Richard W.
Green Reza
Novo Nordisk A S
Raymond Richard L.
Wilk-Orescar Rosemarie R.
LandOfFree
Substituted imidazoles, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoles, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles, their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3499501